We are live on ! Find out more
PGP

Prescott General Partners Portfolio holdings

AUM $1.37B
1-Year Est. Return 23.81%
This Fund
S&P 500
This Quarter Est. Return
-2.82%
1 Year Est. Return
+23.81%
3 Year Est. Return
+67.15%
5 Year Est. Return
+9.62%
10 Year Est. Return
+525.75%
AUM
$1.53B
AUM Growth
-$184M
Cap. Flow
-$122M
Cap. Flow %
-7.99%
Top 10 Hldgs %
99.58%
Holding
12
New
1
Increased
Reduced
Closed
1

Top Buys

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$6.01M

Top Sells

Rank Stock Value
1
LOCK
LifeLock, Inc.
LOCK
+$128M

Sector Composition

Rank Sector Weight
1 Financials 40.42%
2 Industrials 32.62%
3 Consumer Discretionary 8.62%
4 Communication Services 6.79%
5 Technology 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CACC icon
1
Credit Acceptance
CACC
$5.97B
$443M 28.94%
2,222,789
CMPR icon
2
Cimpress
CMPR
$2.33B
$401M 26.2%
4,656,492
W icon
3
Wayfair
W
$11.4B
$132M 8.62%
3,259,784
WRLD icon
4
World Acceptance Corp
WRLD
$840M
$106M 6.89%
2,037,495
YELP icon
5
Yelp
YELP
$1.45B
$104M 6.79%
3,175,523
NSR
6
DELISTED
Neustar Inc
NSR
$97.5M 6.37%
2,941,045
CPRT icon
7
Copart
CPRT
$27B
$74.8M 4.89%
9,668,128
NUS icon
8
Nu Skin
NUS
$251M
$73.1M 4.78%
1,316,941
BFH icon
9
Bread Financial
BFH
$4.35B
$70.3M 4.59%
353,810
GIC icon
10
Global Industrial
GIC
$1.36B
$23.5M 1.53%
2,118,192
LCTX icon
11
Lineage Cell Therapeutics
LCTX
$272M
$6.39M 0.42%
+2,116,666
New +$6.01M
LOCK
12
DELISTED
LifeLock, Inc.
LOCK
-5,365,630
Closed -$128M

Similar funds

Prescott General Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Prescott General Partners held 12 positions worth $1.53B, down 11% from $1.72B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Prescott General Partners withdrew a net $122M in Q1 2017, closing 1 position. Its most notable exit was LifeLock, Inc., an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 40% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Prescott General Partners opened a new position in Lineage Cell Therapeutics worth $6.39M.

  • Prescott General Partners's largest Q1 2017 buy was Lineage Cell Therapeutics: 2,116,666 shares worth $6.39M.
  • Prescott General Partners fully exited LifeLock, Inc. in Q1 2017, selling an estimated $128M.
  • Prescott General Partners's ten largest holdings make up 100% of its $1.53B portfolio in Q1 2017.
  • Prescott General Partners opened 1 new position and closed 1 in Q1 2017.
  • Prescott General Partners's portfolio value fell 11% quarter-over-quarter to $1.53B.

Based on Prescott General Partners's 13F filing for Q1 2017, filed 15 May 2017.